Pharma Journalist -

Lonza announced that it is acquiring a clinical-stage mammalian manufacturing site in the United States from Shire plc. Financial details of the deal were not disclosed. The…
Read More...

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, and Dimension Therapeutics, Inc. announced…
Read More...

Aytu BioScience, Inc., a specialty life sciences company focused on global commercialization of novel products in the field of urology, announced that the company has entered into a…
Read More...

Gilead Sciences, Inc. announced a new licensing agreement with the Medicines Patent Pool (MPP), a United Nations-backed public health organization, to expand access to bictegravir (BIC)…
Read More...

Pilgrim Quality Solutions announced the validated release of SmartSolve Out Of Specification (OOS) Management. Pilgrim’s out-of-specification software drives consistent OOS…
Read More...

GSK announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Benlysta (belimumab) for the treatment of adult patients with systemic lupus erythematosus…
Read More...

Werum IT Solutions has released a standalone version of its PAS-X KPI software product. PAS-X KPI is the only KPI/OEE tool dedicated solely to the pharmaceutical and…
Read More...

TraceLink announced that Tubilux has selected TraceLink's serialization solutions to help its 30+ European pharmaceutical manufacturing customers comply with the rapidly approaching…
Read More...

NewLink Genetics announced that it has entered into a clinical collaboration agreement with AstraZeneca to evaluate the combination of indoximod, NewLink Genetics’ small molecule IDO…
Read More...

AstraZeneca has announced positive top-line results of the Phase III, PINNACLE 4 trial in which Bevespi Aerosphere (glycopyrronium and formoterol fumarate 14.4/9.6 µg) demonstrated a…
Read More...